CBU
CPRX

CIBC Bancorp USA’s Catalyst Pharmaceutical CPRX Stock Holding History

CIBC Bancorp USA’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$401K Buy
12,748
+2,805
+28% +$82.8K ﹤0.01% 1386
2026
Q1 		$246K Buy
+9,943
New +$237K ﹤0.01% 1506
2025
Q3 		$243K Buy
+12,341
New +$254K ﹤0.01% 1180

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIBC Bancorp USA's CPRX Position: Q2 2026 in Review

CIBC Bancorp USA increased its Catalyst Pharmaceutical (CPRX) stake by 28% in Q2 2026, buying an estimated $82.8K and bringing the position to 12,748 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

CIBC Bancorp USA first reported a position in CPRX in Q3 2025 and has held it in 3 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • CIBC Bancorp USA held 12,748 shares of Catalyst Pharmaceutical worth $401K as of Q2 2026.
  • CIBC Bancorp USA bought 2,805 Catalyst Pharmaceutical shares in Q2 2026, an estimated $82.8K.
  • Catalyst Pharmaceutical made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1386 holding.
  • CIBC Bancorp USA first reported a position in Catalyst Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.